Dietary Supplements During Cancer Care

 

Eating healthfully during treatment is important to the healing process. Your body needs a wide variety of nutrients to feel good and recover. Although it is safe to eat nutrient-rich foods, such as vegetables and fruit, it may not be safe to take these nutrients as dietary supplements.

Many people feel that if something is natural, such as a vitamin, a mineral, or an herb, it is safe. This is not necessarily true. You may feel that a dietary supplement couldn’t possibly cause problems with your cancer care, but this may not be true either. Some dietary supplements, natural or otherwise, can interact with your cancer medications.

These interactions may make your cancer treatments more toxic to you. This can worsen side effects and may make you very ill. Another possibility is that a dietary supplement may decrease the effectiveness of your cancer treatments. If this happens, medications and procedures may not work as well as they should. You may not get the full benefits of your cancer treatments.

For all of these reasons, it is safest to err on the side of caution during cancer treatment. Do not take any dietary supplements without talking to your doctor first.

Finally, keep in mind that the dietary supplement industry is nearly unregulated. This means there is little quality control in the manufacture of many dietary supplements and nobody is watching over the claims being made about these products. Because of these issues, you may not get what you pay for, the claims about a supplement may not be true, or even worse, a contaminated dietary supplement could make you sick.

With your health at stake, it makes sense to discuss any dietary supplements that you currently use or are planning to use with your doctor and your entire health care team. Remember, you are a member of your health care team, too. Be safe and take care of yourself with the guidance of your health care providers.

Latest Cancer News
Multiple-agent Therapy with Metronomic Xeloda® and Nexavar® Promising for Metastatic Renal Cell Carcinoma

March 12, 2010 — Researchers from Spain have reported: “Maximum tolerated dose chemotherapy followed by metronomic chemotherapy” is a promising approach for treatment of patients with metastatic renal cell carcinoma (RCC). The details of this study were published early online in Lancet Oncology on February 16, 2010.

Complete Remission Predicts for Long Survival of Patients with Multiple Myeloma

March 12, 2010 — Researchers from the M. D. Anderson Cancer Center have reported that achieving a complete remission (CR) was the dominant prognostic factor for long survival of patients with multiple myeloma (MM). The details of this large retrospective review were published in the March 2010 issue of Bone Marrow Transplantation.

Addition of Hormone Therapy to Radiation Improves Survival in Intermediate-risk, Early-stage Prostate Cancer

March 12, 2010 — Researchers affiliated with the RTOG 94-08 clinical trial have reported that short-term androgen deprivation therapy (ADT) delivered before and during moderate-dose radiation therapy improves survival and reduces risk of recurrence compared with radiation alone in men with intermediate-risk, early-stage prostate cancer. The results of this Phase III study were presented at the 2010 Genitourinary Cancers Symposium in San Francisco on March 5-7.

Select news items provided by Reuters Health